Our previous work, which serves as the rationale for this current study, revealed that DARPP-32 isoforms increase NSCLC cell migration via increasing the expression of NF-κB2–controlled migratory genes by establishing a direct physical interaction with IKKα25. Here, NFKB2 is linked to non-small cell lung carcinoma.